German Drugmaker Rapped for Recordkeeping Issues

Drug Industry Daily
A A
The FDA hit German drug and API manufacturer Boehringer Ingelheim with a Form 483 for recordkeeping shortcomings at its Ingelheim am Rhein facility.

To View This Article:

Login

Subscribe To Drug Industry Daily